缩写名/全名 |
PHARMACEUTICS
Pharmaceutics |
||||||||||||||||
ISSN号 | 1999-4923 | ||||||||||||||||
研究方向 | - | ||||||||||||||||
影响因子 | 2015:0, 2016:0, 2017:3.746, 2018:4.773, 2019:4.421, | ||||||||||||||||
出版国家 | Switzerland | ||||||||||||||||
出版周期 | |||||||||||||||||
年文章数 | 682 | ||||||||||||||||
出版年份 | 2009 | ||||||||||||||||
是否OA | Yes | ||||||||||||||||
审稿周期(仅供参考) | |||||||||||||||||
录用比例 | |||||||||||||||||
投稿链接 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | ||||||||||||||||
投稿官网 | https://www.mdpi.com/journal/pharmaceutics | ||||||||||||||||
h-index | 32 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1999-4923%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery. Author: Kesse S1, Boakye-Yiadom KO2, Ochete BO3, Opoku-Damoah Y4, Akhtar F5, Filli MS6, Asim Farooq M7, Aquib M8, Maviah Mily BJ9, Murtaza G10, Wang B11. Journal: Pharmaceutics. 2019 Feb 13;11(2). pii: E77. doi: 10.3390/pharmaceutics11020077. PubMed DOI |
2. | Targeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed Micelles. Author: Hao F1, Lee RJ2,3, Yang C4, Zhong L5, Sun Y6, Dong S7, Cheng Z8, Teng L9, Meng Q10, Lu J11, Xie J12, Teng L13. Journal: Pharmaceutics. 2019 Feb 21;11(2). pii: E92. doi: 10.3390/pharmaceutics11020092. PubMed DOI |
3. | Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles. Author: Su J1, Zhang R2, Lian Y3, Kamal Z4,5, Cheng Z6, Qiu Y7, Qiu M8. Journal: Pharmaceutics. 2019 Feb 22;11(2). pii: E93. doi: 10.3390/pharmaceutics11020093. PubMed DOI |
4. | Investigation of Crystallization and Salt Formation of Poorly Water-Soluble Telmisartan for Enhanced Solubility. Author: Park C1, Meghani NM2, Shin Y3, Oh E4, Park JB5, Cui JH6, Cao QR7, Tran TT8,9, Tran PH10, Lee BJ11. Journal: Pharmaceutics. 2019 Feb 28;11(3). pii: E102. doi: 10.3390/pharmaceutics11030102. PubMed DOI |
5. | Enhanced Oral Bioavailability, Anti-Tumor Activity and Hepatoprotective Effect of 6-Shogaol Loaded in a Type of Novel Micelles of Polyethylene Glycol and Linoleic Acid Conjugate. Author: Zhang H1, Wang Q2, Sun C3, Zhu Y4, Yang Q5, Wei Q6, Chen J7, Deng W8, Adu-Frimpong M8, Yu J9, Xu X10. Journal: Pharmaceutics. 2019 Mar 6;11(3). pii: E107. doi: 10.3390/pharmaceutics11030107. PubMed DOI |
6. | Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs. Author: He H1,2, Yuan D3, Wu Y4, Cao Y5,6. Journal: Pharmaceutics. 2019 Mar 7;11(3). pii: E110. doi: 10.3390/pharmaceutics11030110. PubMed DOI |
7. | One-Pot Synthesis of Epirubicin-Capped Silver Nanoparticles and Their Anticancer Activity against Hep G2 Cells. Author: Ding J1,2, Chen G3,4, Chen G5, Guo M6,7. Journal: Pharmaceutics. 2019 Mar 15;11(3). pii: E123. doi: 10.3390/pharmaceutics11030123. PubMed DOI |
8. | Hyaluronic Acid-Modified and TPCA-1-Loaded Gold Nanocages Alleviate Inflammation. Author: Zhao J1. Journal: Pharmaceutics. 2019 Mar 25;11(3). pii: E143. doi: 10.3390/pharmaceutics11030143. PubMed DOI |
9. | A Low-Molecular-Weight Polyethylenimine/pDNA-VEGF Polyplex System Constructed in a One-Pot Manner for Hindlimb Ischemia Therapy. Author: Guo X1, Yuan Z2, Xu Y3, Zhao X4, Fang Z5, Yuan WE6. Journal: Pharmaceutics. 2019 Apr 8;11(4). pii: E171. doi: 10.3390/pharmaceutics11040171. PubMed DOI |
10. | Dual pH/Redox-Responsive Mixed Polymeric Micelles for Anticancer Drug Delivery and Controlled Release. Author: Luo Y1,2, Yin X3, Yin X4, Chen A5, Zhao L6, Zhang G7, Liao W8, Huang X9, Li J10, Zhang CY11. Journal: Pharmaceutics. 2019 Apr 11;11(4). pii: E176. doi: 10.3390/pharmaceutics11040176. PubMed DOI |
|
|